Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignanciesChaoting Zhang, Zheming Lu, Shance Li et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 17